StockData

NuCana plc (NCNA) shareholders

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30
$0.86−0.07 (-7.53%)

Close on Nov 16, 2026Market cap $3.58MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.0%
0M of 20.81B shares
Institutional holders
11
5 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Hugh S. Griffith2,829,961,89012.00%13D (active)Jun 20, 2025
Antoine Papiernik
Joint filing with Sofinnova Capital VI FCPR (5.10%), Sofinnova Partners SAS (5.10%) and 5 more
4,987,9755.10%13D (active) amendmentFeb 14, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of NCNAValueChange% of portfolio
StoneX Group Inc.47,0430.00%$71.51KNew0.00%
Citadel Advisors LLC27,0990.00%$41.19K+13,2440.00%
Hrt Financial LP16,8700.00%$25.00KNew0.00%
Glass Jacobson Investment Advisors llc15,0000.00%$22.80K–0.01%
Rhumbline Advisers4,6980.00%$7.14K+9760.00%
Citigroup Inc1880.00%$286New0.00%
Integrated Wealth Concepts LLC1880.00%$286New0.00%
Caitong International Asset Management Co., Ltd50.00%$8+30.00%
Morgan Stanley20.00%$3–0.00%
Acadian Asset Management LLC20.00%$0–0.00%
SBI Securities Co., Ltd.10.00%$2New0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026110M0.0%5 / 30 / 20M0M
Q1 202680M0.0%3 / 03 / 40M0M
Q4 202590M0.0%1 / 32 / 20M0M
Q3 2025100M0.0%4 / 50 / 110M0M
Q2 2025170M0.0%9 / 21 / 40M0M
Q1 2025120M0.0%3 / 13 / 100M0M
Q4 2024200M0.0%8 / 32 / 60M0M
Q3 2024180M0.0%6 / 21 / 10M0M
Q2 2024130M0.0%12 / 00 / 00M0M
Q1 202410M0.0%1 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

1 funds held NCNA in Q2 2026. Each fund counts once per quarter, from its quarter-end report.

FundShares% of NCNAValue% of fundAs of
Blackstone Alternative Multi-Strategy Fund-271-0.00%-$412-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Hugh GriffithChief Executive Officer, Director1,000,0000.00%Mar 18, 2026
Jeffrey D. BlossChief Medical Officer47,1360.00%Jun 23, 2026
Theresa Margaret Ms BruceChief Operating Officer––Apr 16, 2026
David James HarrisonHead of Translational Medicine––Mar 24, 2026
Ian Alexander WebsterSee Remarks––Mar 18, 2026
Elliott M. LevyDirector130.00%Jun 24, 2026
Martin C.B. MellishDirector280.00%Mar 20, 2026
Cyrille LeperlierDirector––Mar 18, 2026
Andrew Martin KayDirector––Mar 18, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
4.9
At 0M shares a day
Change since last report
-4.0%
From 0M shares
Short volume, 20 days
36.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of NuCana's stock actually held short. Settlement fails (shares not delivered on time) peaked at 116,015 shares on Oct 1, 2026 over the last 90 days.

See a number that looks wrong?